Early blood–brain barrier disruption in human focal brain ischemia

Loss of integrity of the blood–brain barrier (BBB) resulting from ischemia/reperfusion is believed to be a precursor to hemorrhagic transformation (HT) and poor outcome. We used a novel magnetic resonance imaging marker to characterize early BBB disruption in human focal brain ischemia and tested for associations with reperfusion, HT, and poor outcome (modified Rankin score >2). BBB disruption was found in 47 of 144 (33%) patients, having a median time from stroke onset to observation of 10.1 hours. Reperfusion was found to be the most powerful independent predictor of early BBB disruption (p = 0.018; odds ratio, 4.09; 95% confidence interval, 1.28–13.1). HT was observed in 22 patients; 16 (72.7%) of those also had early BBB disruption (p < 0.001; odds ratio, 8.11; 95% confidence interval, 2.85–23.1). In addition to baseline severity (National Institutes of Health Stroke Scale score >6), early BBB disruption was found to be an independent predictor of HT. Because the timing of the disruption was early enough to make it relevant to acute thrombolytic therapy, early BBB disruption as defined by this imaging biomarker may be a promising target for adjunctive therapy to reduce the complications associated with thrombolytic therapy, broaden the therapeutic window, and improve clinical outcome. Ann Neurol 2004

[1]  H. Nakajima,et al.  Leptomeningeal contrast enhancement in moyamoya: its potential role in postoperative assessment of circulation through the bypass , 2001, Neuroradiology.

[2]  M. Hoehn,et al.  Prediction of Hemorrhagic Transformation After Thrombolytic Therapy of Clot Embolism: An MRI Investigation in Rat Brain , 2002, Stroke.

[3]  G. Rosenberg,et al.  Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. , 1998, Stroke.

[4]  J. Hallenbeck,et al.  Background review and current concepts of reperfusion injury. , 1990, Archives of neurology.

[5]  J. Mohr.  Thrombolytic therapy for ischemic stroke: from clinical trials to clinical practice. , 2000, JAMA.

[6]  J. Baron,et al.  Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion: a quantitative analysis of infarction volume. , 1997, Stroke.

[7]  G. Hamann,et al.  Hemorrhagic Transformation and Microvascular Integrity during Focal Cerebral Ischemia/Reperfusion , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  I. Wilkinson,et al.  Unilateral leptomeningeal enhancement after carotid stent insertion detected by magnetic resonance imaging. , 2000, Stroke.

[9]  G. Rosenberg,et al.  Closure of the Blood-Brain Barrier by Matrix Metalloproteinase Inhibition Reduces rtPA-Mediated Mortality in Cerebral Ischemia With Delayed Reperfusion , 2003, Stroke.

[10]  A. Elster,et al.  Early cerebral infarction: gadopentetate dimeglumine enhancement. , 1990, Radiology.

[11]  R. Hart,et al.  Hemorrhagic infarcts. , 1986, Stroke.

[12]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[13]  Lian Li,et al.  Patlak plots of Gd‐DTPA MRI data yield blood–brain transfer constants concordant with those of 14C‐sucrose in areas of blood–brain opening , 2003, Magnetic resonance in medicine.

[14]  J. Grotta,et al.  Reperfusion Injury: Demonstration of Brain Damage Produced by Reperfusion after Transient Focal Ischemia in Rats , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  R. Pluta,et al.  Early blood-brain barrier changes in the rat following transient complete cerebral ischemia induced by cardiac arrest , 1994, Brain Research.

[16]  R. D. Adams.  Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. , 1950, The Journal of clinical investigation.

[17]  R. Quisling,et al.  Human brain infarcts: Gd-DTPA-enhanced MR imaging. , 1986, Radiology.

[18]  G. Rosenberg.  Matrix metalloproteinases in neuroinflammation , 2002, Glia.

[19]  Ricardo Prado,et al.  Cerebral Blood Flow Restoration and Reperfusion Injury After Ultraviolet Laser-Facilitated Middle Cerebral Artery Recanalization in Rat Thrombotic Stroke , 2002, Stroke.

[20]  O. R. Blaumanis,et al.  Rapid solute transport throughout the brain via paravascular fluid pathways. , 1990, Advances in neurology.

[21]  N. van Bruggen,et al.  VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. , 1999, The Journal of clinical investigation.

[22]  N. Yamada,et al.  Magnetic resonance imaging of cerebral infarction: Time course of Gd-DTPA enhancement and CT comparison , 2004, Neuroradiology.

[23]  G. Hamann,et al.  Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke , 1998, Journal of neurology, neurosurgery, and psychiatry.

[24]  C. Truwit,et al.  Perfusion MR neuroimaging in patients undergoing balloon test occlusion of the internal carotid artery. , 2001, AJNR. American journal of neuroradiology.

[25]  K. Welch,et al.  Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. , 1998, Stroke.

[26]  M. Lowe,et al.  Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. , 1999, Radiology.

[27]  M. Pessin,et al.  Thrombolytic agents in the treatment of stroke. , 1990, Clinical neuropharmacology.

[28]  J. Arenillas,et al.  Thrombolysis-Related Hemorrhagic Infarction: A Marker of Early Reperfusion, Reduced Infarct Size, and Improved Outcome in Patients With Proximal Middle Cerebral Artery Occlusion , 2002, Stroke.

[29]  J. Koziol,et al.  Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  O. R. Blaumanis,et al.  Evidence for a ‘Paravascular’ fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space , 1985, Brain Research.

[31]  W R Clarke,et al.  Baseline NIH Stroke Scale score strongly predicts outcome after stroke , 1999, Neurology.

[32]  S. Nishiyama,et al.  Detection of reperfusion injury using PET in a monkey model of cerebral ischemia. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  Guo-Yuan Yang,et al.  Reperfusion‐Induced Injury to the Blood‐Brain Barrier After Middle Cerebral Artery Occlusion in Rats , 1994, Stroke.

[34]  G. Krol,et al.  MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis. , 1989, AJNR. American journal of neuroradiology.

[35]  P. Lapchak,et al.  Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke , 2000, Stroke.

[36]  Yueh Z. Lee,et al.  MR imaging enhancement patterns as predictors of hemorrhagic transformation in acute ischemic stroke. , 2003, AJNR. American journal of neuroradiology.

[37]  R. Higashida,et al.  Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .

[38]  G. Rosenberg,et al.  Matrix Metalloproteinases in Cerebrovascular Disease , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[40]  G. D. del Zoppo,et al.  Inflammation after stroke: is it harmful? , 2001 .

[41]  T. Kuroiwa,et al.  The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion , 2004, Acta Neuropathologica.

[42]  R. Busto,et al.  Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats , 1996, Brain Research.

[43]  E. Lo,et al.  Involvement of Matrix Metalloproteinase in Thrombolysis-Associated Hemorrhagic Transformation After Embolic Focal Ischemia in Rats , 2002, Stroke.

[44]  E. Oldfield,et al.  Effects of Nitric Oxide on Reactive Oxygen Species Production and Infarction Size after Brain Reperfusion Injury , 2001, Neurosurgery.

[45]  O. Wu,et al.  Delayed rt-PA Treatment in a Rat Embolic Stroke Model: Diagnosis and Prognosis of Ischemic Injury and Hemorrhagic Transformation with Magnetic Resonance Imaging , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  R. Higashida,et al.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. , 1998, Stroke.

[47]  G. Cosnard,et al.  High signal in cerebrospinal fluid mimicking subarachnoid haemorrhage on FLAIR following acute stroke and intravenous contrast medium , 2000, Neuroradiology.

[48]  H. Weinmann,et al.  Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.